Dose-limiting toxicity affects 31–34% of patients treated with 5-fluorouracil (5-FU). Dihydropyrimidine dehydrogenase (DPD) is a key enzyme in the detoxification of 5-FU; patients with a complete or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results